Prescription drug use in breastfeeding mothers and infant exposure: A register‐based cohort study
British Journal of Clinical Pharmacology · 2025
DOI: 10.1002/bcp.70139 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift British Journal of Clinical Pharmacology, 2025. Verfasst von Ditte Resendal Gotfredsen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Breast Feeding, Prescription Drugs, Milk, Human. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Hebammenwesen und Geburtshilfe, Stillen
Abstract (Originalsprache)
Aims
Breast milk is the optimal infant nutrition; however, many infants may be exposed to prescription drugs if used by their mothers during breastfeeding. The aim of this study was to evaluate the prevalence and patterns of prescription drug use among breastfeeding mothers and to assess the availability of relative infant dose information for these drugs.
Methods
This population‐based cohort study was conducted using nationwide Danish register data from January 2006 to December 2022. All registered mother–infant pairs were included during periods of exclusive breastfeeding. The national health registers were used to identify live births, breastfeeding status and prescription drug use by mothers during exclusive breastfeeding.
Results
Among 534 080 exclusively breastfed infants, 290 845 (54.5%) were breastfed by mothers who used at least 1 prescription drug during the breastfeeding period. The drugs were primarily for haemorrhoids, contraception, infections and pain management. Among individual systemic drugs used during exclusive breastfeeding, 51.5% lacked information on relative infant dose.
Conclusions
This large‐scale cohort study reveals a high prevalence of prescription drug use during exclusive breastfeeding, often involving drugs with unknown safety profiles regarding their transfer into human milk. These findings highlight the need for updated regulatory measures and increased efforts by pharmaceutical companies to ensure reliable infant safety data.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Ditte Resendal Gotfredsen, Ida M Heerfordt, Christina Gade
Zitieren
APA
Gotfredsen, D. R., Heerfordt, I. M., Storm Baden, C., Horwitz, H., Gade, C., & Andersen, J. T. (2025). Prescription drug use in breastfeeding mothers and infant exposure: A register‐based cohort study. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70139
Vancouver
Gotfredsen DR, Heerfordt IM, Storm Baden C, Horwitz H, Gade C, Andersen JT. Prescription drug use in breastfeeding mothers and infant exposure: A register‐based cohort study. British Journal of Clinical Pharmacology. 2025. doi:10.1002/bcp.70139
BibTeX
@article{Gotfredsen2025,
author = {Gotfredsen, Ditte Resendal and Heerfordt, Ida M and Storm Baden, Christoffer and Horwitz, Henrik and Gade, Christina and Andersen, Jon Trærup},
title = {Prescription drug use in breastfeeding mothers and infant exposure: A register‐based cohort study},
journal = {British Journal of Clinical Pharmacology},
year = {2025},
doi = {10.1002/bcp.70139}
}
EUVIMED